Eudragit®-based nanoparticles for controlled release through topical use
Source abstract
Abstract
Eudragit® products are composed of acrylic acid, methacrylic acid, and their esters, which can be used to assemble various drug delivery systems, including polymeric nanoparticles. These nanoparticles make it possible to control the delivery of bioactive molecules (locally and release rate), which is not possible with conventional formulations. In this work, we reviewed the literature to observe the development of nanoparticles for topical application using the different types of Eudragit®. The development of nanoparticles using Eudragit® is known for its reproducible techniques that produce stable and biocompatible particles. The results show that the choice of the polymer was mainly made by the physicochemical properties, looking for polymers that can specifically enhance or avoid the interaction of the nanocarrier with the skin and mucous membranes. Nanoparticles with positive charge and nanometric size interact with physiological membranes to enhance drug efficacy, while particles with negative surface area and pH-dependent release mechanisms aim to reduce adverse effects. These different applications of Eudragit® polymeric nanoparticles could lead to novel products on the market.
Source: expertdata · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Bee Products Chemical Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (64)
Show source-provided references
1. Adabi M, Naghibzadeh M, Adabi M, Zarrinfard MA, Esnaashari SS, Seifalian AM, Faridi-Majidi R, TanimowoAiyelabegan H, Ghanbari H (2017) Biocompatibility and nanostructured materials: applications in nanomedicine. Artif Cells Nanomedicine Biotechnol 45:833–842. https://doi.org/10.1080/21691401.2016.117813410.1080/21691401.2016.1178134 ↗
2. Balzus B, Colombo M, Sahle FF, Zoubari G, Staufenbiel S, Bodmeier R (2016) Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application. Int J Pharm 513:247–254. https://doi.org/10.1016/j.ijpharm.2016.09.03310.1016/j.ijpharm.2016.09.033 ↗
3. Rezende S, Stanisçuaski S, De Lucca L, Raffin A (2003) CARACTERIZAÇÃO E ESTABILIDADE FÍSICO-QUÍMICA DE SISTEMAS POLIMÉRICOS NANOPARTICULADOS PARA ADMINISTRAÇÃO DE FÁRMACOS. Quim Nova 26:726–73710.1590/S0100-40422003000500017 ↗
4. Mora-Huertas CE, Fessi H, Elaissari A (2010) Polymer-based nanocapsules for drug delivery. Int J Pharm 385:113–142. https://doi.org/10.1016/j.ijpharm.2009.10.01810.1016/j.ijpharm.2009.10.018 ↗
5. Kim DK, Dobson J (2009) Nanomedicine for targeted drug delivery. J Mater Chem 19:6294–6307. https://doi.org/10.1039/b902711b10.1039/b902711b ↗
6. Food and Drug Administration (FDA) (2014) Guidance for industry: safety of nanomaterials in cosmetic products, food drug adm 1–16. FDA-2011-D-0489. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-safety-nanomaterials-cosmetic-products
7. Scientific Committee on Consumer Safety (SCCS) (2019) Guidance on the safety assessment of nanomaterials in cosmetics. 1611/19. https://doi.org/10.2875/4044610.2875/40446 ↗
8. Mech A, Wohlleben W, Ghanem A, Hodoroaba VD, Weigel S, Babick F, Brüngel R, Friedrich CM, Rasmussen K, Rauscher H (2020) Nano or not nano? A structured approach for identifying nanomaterials according to the European Commission’s Definition. Small 16, 2002228:1–16. https://doi.org/10.1002/smll.20200222810.1002/smll.202002228 ↗
9. Zoabi A, Touitou E, Margulis K (2021) Recent advances in nanomaterials for dermal and transdermal applications. Colloid Interfaces 5:18. https://doi.org/10.3390/colloids501001810.3390/colloids5010018 ↗
10. Khezri K, Saeedi M, MalekiDizaj S (2018) Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations. Biomed Pharmacother 106:1499–1505. https://doi.org/10.1016/j.biopha.2018.07.08410.1016/j.biopha.2018.07.084 ↗
11. Crucho CIC, Barros MT (2017) Polymeric nanoparticles: a study on the preparation variables and characterization methods. Mater Sci Eng C 80:771–784. https://doi.org/10.1016/j.msec.2017.06.00410.1016/j.msec.2017.06.004 ↗
12. Salvioni L, Morelli L, Ochoa E, Labra M, Fiandra L, Palugan L, Prosperi D, Colombo M (2021) The emerging role of nanotechnology in skincare. Adv Colloid Interface Sci 293:102437. https://doi.org/10.1016/j.cis.2021.10243710.1016/j.cis.2021.102437 ↗
13. Patra CN, Priya R, Swain S, Kumar Jena G, Panigrahi KC, Ghose D (2017) Pharmaceutical significance of Eudragit: A review. Futur J Pharm Sci 3:33–45. https://doi.org/10.1016/j.fjps.2017.02.00110.1016/j.fjps.2017.02.001 ↗
14. Antonow MB, Lorenzoni R, Barbosa GM, Ourique AF, Gomes P, Raffin RP (2016) Development and physicochemical characterization of desonide-loaded nanocapsule suspensions. Adv Mater Sci Eng 7395896:12 https://doi.org/10.1155/2016/739589610.1155/2016/7395896 ↗
15. Prusty A, Gupta BK (2017) Role of chitosan and Eudragit in polymer-based extended release matrix tablets—a review. Int J Pharm Sci Res 8:4973–4982. https://doi.org/10.13040/IJPSR.0975-8232.8(12).4973-8210.13040/IJPSR.0975-8232.8(12).4973-82 ↗
16. Verma P, Gupta RN, Jha AK, Pandey R (2013) Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide. Drug Deliv 20:269–276. https://doi.org/10.3109/10717544.2013.83441710.3109/10717544.2013.834417 ↗
17. Hao S, Wang B, Wang Y, Zhu L, Wang B, Guo T (2013) Preparation of Eudragit L 100–55 enteric nanoparticles by a novel emulsion diffusion method. Colloids Surfaces B Biointerfaces 108:127–133. https://doi.org/10.1016/j.colsurfb.2013.02.03610.1016/j.colsurfb.2013.02.036 ↗
18. Fontana MC, Beckenkamp A, Buffon A, Beck RCR (2014) Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells. Int J Nanomedicine 9:2979–2991. https://doi.org/10.2147/IJN.S6285710.2147/IJN.S62857 ↗
19. Gandhi A, Jana S, Sen KK (2014) In-vitro release of acyclovir loaded Eudragit RLPO® nanoparticles for sustained drug delivery. Int J Biol Macromol 67:478–482. https://doi.org/10.1016/j.ijbiomac.2014.04.01910.1016/j.ijbiomac.2014.04.019 ↗
20. Torres-Flores G, Nazende GT, Emre TA (2019) Preparation of Fenofibrate loaded Eudragit L100 nanoparticles by nanoprecipitation method. Mater Today Proc 13:428–435. https://doi.org/10.1016/j.matpr.2019.03.17610.1016/j.matpr.2019.03.176 ↗
21. Pereira MP, de Gomes MG, Izoton JC, Nakama KA, dos Santos RB, Pinto Savall AS, Ramalho JB, Roman SS, Luchese C, Cibin FW, Pinton S, Haas SE (2019) Cationic and anionic unloaded polymeric nanocapsules: toxicological evaluation in rats shows low toxicity. Biomed Pharmacother 116:109014. https://doi.org/10.1016/j.biopha.2019.10901410.1016/j.biopha.2019.109014 ↗
22. Wang X, Wang M, Wang Q, Yuan Y, Hao Q, Bi Y, He Y, Zhao J, Hao J (2022) Fabrication and in vitro/in vivo characterization of Eudragit enteric nanoparticles loaded with indomethacin. Chem Pap 76:1119–1133. https://doi.org/10.1007/s11696-021-01921-310.1007/s11696-021-01921-3 ↗
23. Yu Y-Q, Yang X, Wu X-F, Fan Y-B (2021) Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front Bioeng Biotechnol 9:1–17. https://doi.org/10.3389/fbioe.2021.64655410.3389/fbioe.2021.646554 ↗
24. Guterres SS, Alves MP, Pohlmann AR (2007) Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2:117739280700200. https://doi.org/10.1177/11773928070020000210.1177/117739280700200002 ↗
25. Pohlmann AR, Detoni CB, Paese K, Coradini K, Beck RCR, Guterres SS (2016) Polymeric Nanocapsules for Topical Delivery. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer Berlin Heidelberg, Berlin. Heidelberg. 201–221. https://doi.org/10.1007/978-3-662-47862-2_1310.1007/978-3-662-47862-2_13 ↗
26. Balzus B, Sahle FF, Hönzke S, Gerecke C, Schumacher F, Hedtrich S, Kleuser B, Bodmeier R (2017) Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium. Eur J Pharm Biopharm 115:122–130. https://doi.org/10.1016/j.ejpb.2017.02.00110.1016/j.ejpb.2017.02.001 ↗
27. Rençber S, Karavana SY, Yılmaz FF, Eraç B, Nenni M, Ozbal S, Pekçetin Ç, Gurer-Orhan H, Hoşgör Limoncu M, Güneri P, Ertan G (2016) Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. Int J Nanomedicine 11:2641–2653. https://doi.org/10.2147/IJN.S10376210.2147/IJN.S103762 ↗
28. El-Nahas AE, Allam AN, Abdelmonsif DA, El-Kamel AH (2017) Silymarin-loaded Eudragit nanoparticles: formulation, characterization, and hepatoprotective and toxicity evaluation. AAPS PharmSciTech 18:3076–3086. https://doi.org/10.1208/s12249-017-0799-910.1208/s12249-017-0799-9 ↗
29. Goswami A, Patel N, Bhatt V, Raval M, Kundariya M, Sheth N (2022) Lycopene loaded polymeric nanoparticles for prostate cancer treatment: formulation, optimization using Box-behnken design and cytotoxicity studies. J Drug Deliv Sci Technol 67:102930. https://doi.org/10.1016/j.jddst.2021.10293010.1016/j.jddst.2021.102930 ↗
30. Turanlı Y, Acartürk F (2022) Preparation and characterization of colon-targeted pH/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur J Pharm Sci 171:106122. https://doi.org/10.1016/j.ejps.2022.10612210.1016/j.ejps.2022.106122 ↗
31. dos Chavez PS, Ourique AF, Frank LA, Pohlmann AR, Guterres SS, Beck RCR (2017) Carvedilol-loaded nanocapsules: mucoadhesive properties and permeability across the sublingual mucosa. Eur J Pharm Biopharm 114:88–95. https://doi.org/10.1016/j.ejpb.2017.01.00710.1016/j.ejpb.2017.01.007 ↗
32. Jahangir MA, Khan R, Sarim Imam S (2018) Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance. Artif Cells Nanomed Biotech 46:66–78. https://doi.org/10.1080/21691401.2017.141193310.1080/21691401.2017.1411933 ↗
33. Asfour MH, Mohsen AM (2018) Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line. J Adv Res 9:17–26. https://doi.org/10.1016/j.jare.2017.10.00310.1016/j.jare.2017.10.003 ↗
34. Catalan-Figueroa J, Boisset CB, Jara MO, Flores ME, Moreno-Villoslada I, Fiedler JL, Morales JO (2018) A mechanistic approach for the optimization of loperamide loaded nanocarriers characterization: diafiltration and mathematical modeling advantages. Eur J Pharm Sci 125:215–222. https://doi.org/10.1016/j.ejps.2018.10.00210.1016/j.ejps.2018.10.002 ↗
35. Giaretta M, Bianchin MD, Kanis LA, Contri RV, Külkamp-Guerreiro IC (2019) Development of innovative polymer-based matricial nanostructures for ritonavir oral administration. J Nanomater 8619819:10. https://doi.org/10.1155/2019/861981910.1155/2019/8619819 ↗
36. Sunoqrot S, Abujamous L (2019) pH-sensitive polymeric nanoparticles of quercetin as a potential colon cancer-targeted nanomedicine. J Drug Deliv Sci Technol 52:670–676. https://doi.org/10.1016/j.jddst.2019.05.03510.1016/j.jddst.2019.05.035 ↗
37. Krieser K, Emanuelli J, Daudt RM, Bilatto S, Willig JB, Guterres SS, Pohlmann AR, Buffon A, Correa DS, Külkamp-Guerreiro IC (2020) Taste-masked nanoparticles containing Saquinavir for pediatric oral administration. Mater Sci Eng C 117:111315. https://doi.org/10.1016/j.msec.2020.11131510.1016/j.msec.2020.111315 ↗
38. Nejati L, Maram NS, Ahmady AZ (2021) Preparation of Gentamicin sulfate nanoparticles using Eudragit RS-100 and evaluation of their physicochemical properties. Int J Nanosci 20:1–13. https://doi.org/10.1142/S0219581X2150049610.1142/S0219581X21500496 ↗
39. Benson AC, Watkinson HAE (2012) Topical and transdermal drug delivery: principlesand practice. Skin Structure, Function, and Permeation. John Wiley & Sons, Inc., Hoboken. 2011019937:1–22. https://doi.org/10.1002/978111814050510.1002/9781118140505 ↗
40. Wu L, Zhang J, Watanabe W (2011) Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 63:456–469. https://doi.org/10.1016/j.addr.2011.02.00110.1016/j.addr.2011.02.001 ↗
41. Contri RV, Fiel LA, Alnasif N, Pohlmann AR, Guterres SS, Schäfer-Korting M (2016) Skin penetration and dermal tolerability of acrylic nanocapsules: influence of the surface charge and a chitosan gel used as vehicle. Int J Pharm 507:12–20. https://doi.org/10.1016/j.ijpharm.2016.03.04610.1016/j.ijpharm.2016.03.046 ↗
42. Beber TC, De Andrade DF, Dos Santos Chaves P, Pohlmann AR, Guterres SS, Ruver Beck RC (2016) Cationic polymeric nanocapsules as a strategy to target dexamethasone to viable epidermis: skin penetration and permeation studies. J Nanosci Nanotechnol 16:1331–1338. https://doi.org/10.1166/jnn.2016.1167010.1166/jnn.2016.11670 ↗
43. Contri RV, Kulkamp-Guerreiro IC, da Silva SJ, Frank LA, Pohlmann AR, Guterres SS (2016) Nanoencapsulation of rose-hip oil prevents oil oxidation and allows obtainment of gel and film topical formulations. AAPS PharmSciTech 17:863–871. https://doi.org/10.1208/s12249-015-0379-910.1208/s12249-015-0379-9 ↗
44. Rosa P, Friedrich ML, dos Santos J, Librelotto DRN, Maurer LH, Emanuelli T, De C, da Silva B, Adams AIH (2019) Desonide nanoencapsulation with açai oil as oil core: physicochemical characterization, photostability study and in vitro phototoxicity evaluation. J Photochem Photobiol B Biol 199:111606. https://doi.org/10.1016/j.jphotobiol.2019.11160610.1016/j.jphotobiol.2019.111606 ↗
45. Cervi VF, Saccol CP, Sari MHM, Martins CC, da Rosa LS, Ilha BD, Soares FZ, Luchese C, Wilhelm EA, Cruz L (2021) Pullulan film incorporated with nanocapsules improves pomegranate seed oil anti-inflammatory and antioxidant effects in the treatment of atopic dermatitis in mice. Int J Pharm 609:121144. https://doi.org/10.1016/j.ijpharm.2021.12114410.1016/j.ijpharm.2021.121144 ↗
46. de Araújo Lopes A, da Fonseca FN, Rocha TM, de Freitas LB, Araújo EVO, Wong DVT, Lima Júnior RCP, Leal LKAM (2018) Eugenol as a promising molecule for the treatment of dermatitis: antioxidant and anti-inflammatory activities and its nanoformulation. Oxid Med Cell Longev 2018:1–13. https://doi.org/10.1155/2018/819484910.1155/2018/8194849 ↗
47. Dong P, Sahle FF, Lohan SB, Saeidpour S, Albrecht S, Teutloff C, Bodmeier R, Unbehauen M, Wolff C, Haag R, Lademann J, Patzelt A, Schäfer-Korting M, Meinke MC (2019) pH-sensitive Eudragit® L 100 nanoparticles promote cutaneous penetration and drug release on the skin. J Control Release 295:214–222. https://doi.org/10.1016/j.jconrel.2018.12.04510.1016/j.jconrel.2018.12.045 ↗
48. Breiding MJ (2014) Nanoparticles for drug delivery to the anterior segment of the eye. Physiol Behav 63:1–18. https://doi.org/10.1016/j.addr.2017.04.001.Nanoparticles10.1016/j.addr.2017.04.001.Nanoparticles ↗
49. Duxfield L, Sultana R, Wang R, Englebretsen V, Deo S, Swift S, Rupenthal I, Al-Kassas R (2016) Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery. Pharm Dev Technol 21:172–179. https://doi.org/10.3109/10837450.2015.109183910.3109/10837450.2015.1091839 ↗
50. Quinteros DA, Ferreira LM, Schaffazick SR, Palma SD, Allemandi DA, Cruz L (2016) Novel polymeric nanoparticles intended for ophthalmic administration of Acetazolamide. J Pharm Sci 105:3183–3190. https://doi.org/10.1016/j.xphs.2016.06.02310.1016/j.xphs.2016.06.023 ↗
51. Kesarla R, Tank T, Vora PA, Shah T, Parmar S, Omri A (2016) Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel. Drug Deliv 23:2363–2370. https://doi.org/10.3109/10717544.2014.98733310.3109/10717544.2014.987333 ↗
52. Morsi N, Ghorab D, Refai H, Teba H (2016) Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm 506:57–67. https://doi.org/10.1016/j.ijpharm.2016.04.02110.1016/j.ijpharm.2016.04.021 ↗
53. Mohammadi G, Mirzaeei S, Taghe S, P. (2019) Mohammadi, Preparation and evaluation of Eudragit® L100 nanoparticles loaded impregnated with kt tromethamine loaded PVA-HEC insertions for ophthalmic drug delivery. Adv Pharm Bull 9:593–600. https://doi.org/10.15171/apb.2019.06810.15171/apb.2019.068 ↗
54. Castro BFM, De G, Fulgêncio O, Domingos LC, Cotta OAL, Silva-Cunha A, Fialho SL (2020) Positively charged polymeric nanoparticles improve ocular penetration of tacrolimus after topical administration. J. Drug Deliv. Sci. Technol 60:101912. https://doi.org/10.1016/j.jddst.2020.10191210.1016/j.jddst.2020.101912 ↗
55. de Lima JA, Paines TC, Motta MH, Weber WB, dos Santos SS, Cruz L, C. de B. da Silva, (2017) Novel Pemulen/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: evaluation of mucoadhesion and vaginal permeation. Mater Sci Eng C 79:886–893. https://doi.org/10.1016/j.msec.2017.05.03010.1016/j.msec.2017.05.030 ↗
56. Pandey M, Choudhury H, Abdul-Aziz A, Bhattamisra SK, Gorain B, Carine T, Toong TW, Yi NJ, Yi LW (2021) Promising drug delivery approaches to treat microbial infections in the vagina: a recent update. Polymers (Basel) 23:1–65. https://doi.org/10.3390/polym1301002610.3390/polym13010026 ↗
57. Englert AV, Verdi CM, Santos RCV, Cruz L, Sari MHM (2020) Diphenyl Diselenide and Clotrimazole Co-loaded into Eudragit® RS 100 nanocapsules formulation has superior antioxidant potential and promising anti-candida activity. Brazilian Arch Biol Technol 63:e20200087. https://doi.org/10.1590/1678-4324-202020008710.1590/1678-4324-2020200087 ↗
58. dos Reis FP, Rigo GV, Nogueira CW, Tasca T, Sari MHM, Cruz L (2022) Locust Bean Gum Nano-Based hydrogel for vaginal delivery of diphenyl diselenide in the treatment of Trichomoniasis: formulation characterization and in vitro biological evaluation. Pharmaceutics 14(10):2112. https://doi.org/10.3390/pharmaceutics1410211210.3390/pharmaceutics14102112 ↗
59. Osmari BF, Giuliani LM, Reolon JB, Rigo GV, Tasca T, Cruz L (2020) Gellan gum-based hydrogel containing nanocapsules for vaginal indole-3-carbinol delivery in trichomoniasis treatment. Eur J Pharm Sci 151:105379. https://doi.org/10.1016/j.ejps.2020.10537910.1016/j.ejps.2020.105379 ↗
60. Melo CM, Cardoso JF, Perassoli FB, de Oliveira Neto AS, Pinto LM, de Freitas Marques MB, da Nova Mussel W, Magalhães JT, de Lima Moura SA, de Freitas Araújo MG, da Silva GR (2020) Amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis. Carbohydr Polym 230:115608. https://doi.org/10.1016/j.carbpol.2019.11560810.1016/j.carbpol.2019.115608 ↗
61. Giri LHC (2016) Namita; Oh, Byeongtaek, Stimuli-sensitive nanoparticles for multiple anti-HIV microbicides. J Nanoparticles Res. https://doi.org/10.1007/s11051-016-3440-310.1007/s11051-016-3440-3 ↗
62. Ali ME, Lamprecht A (2013) Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation. Int J Pharm 456:135–142. https://doi.org/10.1016/j.ijpharm.2013.07.07710.1016/j.ijpharm.2013.07.077 ↗
63. Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK (2018) Review on nanoparticles and nanostructured materials: History, sources, toxicity and regulations. Beilstein J Nanotechnol 9:1050–1074. https://doi.org/10.3762/bjnano.9.9810.3762/bjnano.9.98 ↗
64. Saifi MA, Khan W, Godugu C (2018) Cytotoxicity of nanomaterials: using nanotoxicology to address the safety concerns of nanoparticles. Pharm Nanotechnol 6:3–16. https://doi.org/10.2174/221173850566617102315292810.2174/2211738505666171023152928 ↗